Skip to main content
. 2011 Mar;23(1):33–37. doi: 10.1007/s11670-011-0033-3

Table 5. Combined effects of polymorphisms of VDR on NSCLC survival.

Combined Genotypes (Unfavorable Genotypes) Patients Deaths MST (Months) Crude HR (95% CIs) Adjusted HR (95% CIs)*
       0 485 257 26.4 1.00 1.00
       1 69 42 20.0 1.39 (1.01-1.93) 1.54(1.10-2.14)
       2 14 12 17.4 2.16 (1.21-3.86) 2.27(1.26-4.08)
Locus trend P for trend = 0.003 1.44 (1.14-1.80) 1.52(1.21-1.91)

*Adjusted for age, gender, smoking status, stage, histology, surgical operation and chemotherapy or radiation treatment.